GLP-1 blindness risk: who gets eye strokes on Ozempic, what to watch for

Doctor Eye Health says the absolute risk is low, 2 in 10,000 per year, but the vision loss is permanent. Five risk factors put you in the vulnerable group.

GLP 1 Blindness Risk | Should You Be Worried?

GLP-1 medications like Ozempic and Wegovy are now tangled in legal cases over vision loss and blindness. Not a rash, not nausea. Permanent blindness.

About 12% of the US population is either taking or has tried a GLP-1, mostly for diabetes but increasingly for weight loss. The drugs are powerful. They control blood sugar, suppress appetite and reduce cardiovascular risk. With that power comes the need to watch for side effects, especially the grave ones.

The most serious vision side effect reported is NAION, nonarteritic anterior ischemic optic neuropathy. That is a stroke inside the optic nerve. Blood flow to the nerve gets reduced or blocked. The nerve dies. The vision does not come back.

The hard reality of this type of vision loss is that it's usually permanent. Sometimes there can be a subtle improvement within the first month or two, but most cases the vision loss is permanent.Doctor Eye Health

What an eye stroke feels like

Symptoms of NAION usually include sudden, painless vision loss in one eye. The loss is often altitudinal, meaning the bottom half of your vision disappears, or the top half goes black.

Some people notice color vision loss in one eye, a desaturation where colors look washed out compared to the other eye. The medical term is dyschromatopsia.

Most of the time, the vision loss is permanent. Occasionally there is subtle improvement in the first month or two, but that is the exception. Most cases do not recover.

Why this matters if you haven’t started yet: If you are starting a GLP-1 and already have diabetes or high blood pressure, you are starting with a higher baseline risk for this kind of stroke. The drug may add to that risk.

The numbers: 2 in 10,000 per year

Several observational studies estimate that GLP-1 users have about a twofold risk of NAION compared to non-users. That sounds alarming until you look at the absolute risk.

The baseline risk of NAION is about 1 in 10,000 cases per year. On a GLP-1, that risk goes to about 2 in 10,000 per year. Still rare, but not zero.

The criticism of these studies is that people taking GLP-1s often already have diabetes, high blood pressure, high cholesterol and other factors that increase NAION risk on their own. The drug may not be the sole cause, but it appears to be a contributor.

When the first observational studies came out in 2024, several people commented that they had experienced exactly this: a stroke in the eye after starting a GLP-1. The consequences, though rare, are real.

Two other eye risks on GLP-1s

In the SUSTAIN-6 trial, people on GLP-1s who already had diabetic retinopathy, bleeding in the back of the eye from diabetes, had a higher risk of worsening bleeding.

If you are diabetic, already have some level of retinopathy and are starting or considering a GLP-1, follow up with your eye doctor so they can monitor whether the bleeding is getting worse and whether it needs treatment.

A smaller study also reported that people who are diabetic and at risk of macular degeneration had an increased risk of neovascular macular degeneration on GLP-1s. Again, the absolute risk is very low, but it is on the radar.

Who is most at risk

The American Optometric Association's evidence-based committee reviewed the published research and issued a clinical report identifying the high-risk group.

People over age 50 who have diabetes, high blood pressure or high cholesterol are at higher risk. People with obstructive sleep apnea may also be more vulnerable.

Two anatomical factors matter. One is a small optic nerve, sometimes called a disc at risk. Some people have larger optic nerves, some have smaller ones. A small nerve is more congested, and blood vessels may have a harder time getting through.

The other is optic nerve head drusen, calcium deposits that build up in the nerve and make it congested. Your eye doctor can tell you if you have either of these by examining your optic nerve with a slit lamp.

Why this matters if you haven’t started yet: If you are over 50, have diabetes or high blood pressure and are starting a GLP-1, ask your doctor if you should see an eye specialist before you start or within the first month.

What to do before you start, and after

It is now recommended to have a baseline, in-person, comprehensive dilated eye exam either before starting a GLP-1 or within one month of starting.

After that, doctors recommend follow-up exams every 12 to 18 months to keep a closer watch. If you notice any vision changes, sudden loss, color desaturation or a curtain dropping over part of your vision, call your doctor right away.

Doctor Eye Health emphasizes he is not telling anyone to stop these medications or avoid them. They help with diabetes, weight loss and cardiovascular protection. But from an eye care standpoint, the risk exists, and certain people are more vulnerable.

I am in no way telling you to either stop these medications without talking first to your prescribing doctor or to avoid taking these medications because we know they can help quite a bit with diabetes and weight loss.Doctor Eye Health

If you have already lost vision from a GLP-1, Doctor Eye Health suggests asking your doctor about a referral to a low vision specialist. They can help you maximize the usable vision you have left and teach you how to live functionally with what remains. He says eye doctors do not talk about that resource enough.

The risk is low. The consequences are not. Five risk factors, one baseline exam and a follow-up schedule. That is what stands between rare and permanent.

Questions people ask

What is the risk of blindness from Ozempic or other GLP-1 medications?

The absolute risk of NAION, an eye stroke that causes permanent vision loss, is about 2 in 10,000 per year for people on GLP-1s, compared to 1 in 10,000 for non-users. The risk is low but the vision loss is usually permanent.

What are the symptoms of an eye stroke from a GLP-1?

Sudden, painless vision loss in one eye, often affecting the top or bottom half of your vision. Some people notice color desaturation in one eye, where colors look washed out. If you experience this, call your doctor immediately.

Should I get an eye exam before starting Ozempic or Wegovy?

Yes. It is now recommended to have a baseline comprehensive dilated eye exam either before starting a GLP-1 or within one month of starting, especially if you are over 50, have diabetes, high blood pressure or sleep apnea.

DE
Doctor Eye Health

Doctor Eye Health is an optometrist who covers eye health topics on YouTube, including the vision side effects of systemic medications. 903,332 views on the original video.

Watch the original on YouTube →

Trending Topics